Journal Club - Recent Additions

July - 2021


Showing Journal 1 of 2

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

P Guimaraes, D Quirk, R Furtado, for the STOP-COVID Trial Investigators New Eng J Med, 2021,


The STOP-COVID Trial examines the effect of the janus kinase inhibitor tofacitinib, on the progression of hospitalised patients with COVID-19, to death or respiratory failure. 

 Tofacitinib is an oral JAK inhibitor, similar to baricitinib, that was tested in the ACTT-2...


Previous Comments

No Comments yet.